Bli medlem
Bli medlem

Du är här

2016-10-20

Nomination Committee for Episurf Medical’s AGM 2017

mmittee for Episurf Medical’s AGM 2017

This information was published, 2016-10-20 12:30 CEST (GLOBE NEWSWIRE) --

The Nomination Committee for Episurf Medical shall have four members. The
members are selected by the three largest shareholder/owner groups in the
company who are entitled to appoint one member each. In addition, the Chairman
of the Board is to be appointed to the Nomination Committee.

In accordance with the above principles, the Nomination Committee consists of
the following four members:

Dennis D. Stripe, Chairman of the Board of Episurf Medical AB

Amin Omrani, representing Serendipity Ixora AB

Christian Krüeger, representing LMK Forward AB

Björg Arnardóttir, representing Kaupthing HF.

The Nomination Committee has appointed Amin Omrani as its chairman.

The shareholders having appointed members of the Nomination Committee together
represent approximately 41,9 per cent of the voting rights for all shares in
Episurf Medical.

Shareholders may contact the Committee with proposals regarding the work of the
committee. Proposals must be sent to the Chairman of the nomination committee,
via ir@episurf.com.

For more information, please visit the company website: www.episurf.com

For more information, please contact:

Pål Ryfors, CFO, Episurf Medical

Tel: +46 709 62 36 69

Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a
more active, healthier life through the availability of minimally invasive and
personalized treatment alternatives. Episurf Medical’s Episealer® personalized
implants and Epiguide® surgical drill guides are developed for treating
localized cartilage injury in joints. Episurf Medical’s ?iFidelity® system
enables implants to be cost-efficiently tailored to each individual’s unique
injury for the optimal fit and minimal intervention. Episurf Medical’s head
office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq
Stockholm. For more information, go to the company’s website: www.episurf.com.

This information is information that Episurf Medical AB is obliged to make
public pursuant to the Financial Instruments Trading Act.

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.